Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

What Makes Asia Appealing For Clinical Trials?

Executive Summary

Asia is continuing to emerge as a global hot spot for clinical trials, helped by positive factors including patient availability and competitive costs, but challenges remain, a recent conference in Seoul heard.

You may also be interested in...



Green Cross Halts US, Europe GreenGene F Trials To Focus On China

Green Cross has overhauled the global development strategy for its hemophilia A therapy GreenGene F, halting slow-progressing Phase III trials in the US and Europe and shifting its focus instead to the fast-growing China market.

Alteplase Trial Puts ENCHANTED Asian Sites On The Map

As well as establishing the benefits of lower dosing, new results from a multinational clinical trial with clot-buster alteplase have highlighted the strong performance of Asian study sites, breaking some perceptions in the process.

Asia Deal Watch: Astellas Looks To Next-Gen AAV Vectors Despite Gene Therapy Clinical Setbacks

Astellas inks agreement with Dyno Therapeutics for access to its CapsidMap platform for novel AAV vectors. Taiho takes option to Arcus TIGIT-targeted antibody candidates.

Topics

Related Companies

UsernamePublicRestriction

Register

SC097626

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel